HomeFBIOP • NASDAQ
add
Fortress Biotech 9 375 Cumulative Redeemable Perpetual Pref Shs Series A
Previous close
$5.27
Day range
$5.05 - $5.45
Year range
$4.86 - $18.00
Market cap
39.91M USD
Avg Volume
22.36K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 14.90M | -14.32% |
Operating expense | 20.82M | -14.80% |
Net income | -10.95M | 55.81% |
Net profit margin | -73.50 | 48.42% |
Earnings per share | — | — |
EBITDA | -23.95M | 47.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 76.20M | -2.33% |
Total assets | 145.68M | -19.39% |
Total liabilities | 160.28M | -18.50% |
Total equity | -14.60M | — |
Shares outstanding | 22.81M | — |
Price to book | 6.67 | — |
Return on assets | -40.50% | — |
Return on capital | -79.28% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -10.95M | 55.81% |
Cash from operations | -21.84M | 34.40% |
Cash from investing | — | — |
Cash from financing | 14.26M | 146.95% |
Net change in cash | -7.57M | 88.48% |
Free cash flow | -12.56M | 63.48% |
About
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
Founded
2006
Headquarters
Website
Employees
186
